ESR1 signalling in ovarian cancer involves many interconnected pathways including IL6/STAT3, PI3K/AKT, and MAPK1, making it difficult to elucidate the mechanisms directly responsible for E2-stimulated tumour growth [4, 5]. Here, ESR1 is linked to neoplasm.